Form 4: NeuroOne Medical Technologies CEO David A. Rosa Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
David A. Rosa, CEO and President of NeuroOne Medical Technologies, disposed of 2,239 shares of common stock on August 31, 2024, to cover tax obligations.
Summary
- On August 31, 2024, David A. Rosa, the CEO and President of NeuroOne Medical Technologies Corp, disposed of 2,239 shares of common stock.
- The transaction was executed at a price of $0.7964 per share.
- This disposal was to cover tax obligations.
- Following the transaction, Mr. Rosa directly owns 1,151,183 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a standard Form 4 filing, indicating a routine transaction. It doesn't convey any particularly positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction is a routine disclosure and doesn't necessarily indicate a change in the company's outlook.
Stakeholder Impact
- The disposal of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 08/31/2024 | Date of transaction: David A. Rosa disposed of shares. |
| 09/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.